2023
DOI: 10.2337/dc22-1514
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study

Abstract: OBJECTIVE To determine whether the benefits of dapagliflozin in patients with type 2 diabetes and chronic kidney disease (CKD) in the Dapagliflozin And Prevention of Adverse Outcomes in CKD trial (DAPA-CKD) varied by background glucose-lowering therapy (GLT). RESEARCH DESIGN AND METHODS We randomized 4,304 adults (including 2,906 with type 2 diabetes) with a baseline estimated glomerular filtration rate (eGFR) 25–75 mL/min/1.… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…The armamentarium of the single renin-angiotensin system (RAS) blockade is further expanded with the use of sparsentan, a dual endothelin angiotensin receptor antagonist (DEARA) whose reno-protective effects were evaluated in PROTECT trial versus irbesartan [42]. Furthermore, sodium-glucose cotransporter-2 inhibitors (SGLT2i) constitute a novel therapeutic approach with promising results, although the precise mechanism of action has not been deciphered yet [43,44].…”
Section: Discussionmentioning
confidence: 99%
“…The armamentarium of the single renin-angiotensin system (RAS) blockade is further expanded with the use of sparsentan, a dual endothelin angiotensin receptor antagonist (DEARA) whose reno-protective effects were evaluated in PROTECT trial versus irbesartan [42]. Furthermore, sodium-glucose cotransporter-2 inhibitors (SGLT2i) constitute a novel therapeutic approach with promising results, although the precise mechanism of action has not been deciphered yet [43,44].…”
Section: Discussionmentioning
confidence: 99%